Influence of <i>CYP2D6</i> genetic variation on adverse events with propafenone in the pediatric and young adult population-Reference-Cited by-同舟云学术

Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population

Author:

Sunthankar Sudeep D.¹²^ORCID,Kannankeril Prince J.¹²^ORCID,Gaedigk Andrea³^ORCID,Radbill Andrew E.¹,Fish Frank A.¹,Van Driest Sara L.²⁴⁵

Affiliation:

1. Thomas P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics Vanderbilt University Medical Center| Nashville Tennessee USA

2. Center for Pediatric Precision Medicine Vanderbilt University Medical Center Nashville Tennessee USA

3. Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation Children's Mercy Kansas City Kansas City Missouri USA

4. Division of Clinical Pharmacology, Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

5. Division of General Pediatrics, Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

Funder

Burroughs Wellcome Fund

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference35 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献